Purchase Order 75N95D19P00211
Award Date 9/17/19
Potential Completion Date 10/17/19
Potential Value $25K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $24,970.00 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract, which has no set-aside designation, is for the delivery of various cell culture research products, such as cell isolation kits, cell culture media, and automated cell separation instruments, to support biomedical...
- Stemcell Technologies Inc., a Canadian biotechnology company, was awarded a $7,485 firm-fixed-price purchase order contract (HHSN272201100756P) by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The contract, which does not have a small business set-aside, was awarded on August 10, 2011 with a completion date of July 30, 2012. Stemcell Technologies Inc. primarily...
- This federal contract award, valued at $4,356.00, was made by the National Institutes of Health (NIH) to Stemcell Technologies Inc., a subsidiary of the Canadian company Stemcell Technologies. The contract is a Firm Fixed Price Purchase Order that runs through October 18, 2024. Stemcell Technologies Inc. is not a small business set-aside, but the company has been awarded some small business set-aside contracts in the past, indicating flexibility in its contracting status. Stemcell Technologies...
- This federal contract award was granted to Stemcell Technologies Inc., a subsidiary of the Canadian biotechnology company Stemcell Technologies, by the Department of Health and Human Services (HHS). The contract, worth $24,908.80, is a firm fixed-price purchase order for the company to provide a range of specialized biological materials, laboratory supplies, scientific equipment, and proprietary products to support biomedical research initiatives across various HHS agencies, including the...
- This is a $18,772.80 firm fixed-price purchase order awarded to Stemcell Technologies Inc. by the National Institutes of Health (NIH) Clinical Center on November 13, 2024. Stemcell Technologies Inc. is a subsidiary of the Canadian biotechnology company Stemcell Technologies. This contract is not set aside for small businesses. The award provides specialized biological materials, laboratory supplies, scientific equipment, and proprietary products to support biomedical research initiatives...
- This federal contract award was issued by the National Institutes of Health (NIH) Clinical Center to Stemcell Technologies Inc., a subsidiary of the Canadian company Stemcell Technologies. The $10,313.00 Firm Fixed Price contract is for the provision of a range of specialized biological materials, laboratory supplies, scientific equipment, and proprietary products to support biomedical research initiatives across various NIH institutes and centers. Stemcell Technologies Inc. holds a single-award...
- This firm-fixed-price purchase order contract was awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Stemcell Technologies Inc., a subsidiary of the Canadian company Stemcell Technologies. The $11,593.80 award is for the delivery of HU PB MONOCYTES, CRYO, 4X10E7 (2 VIALS), with a completion date of July 15, 2024. The contract has no set-aside designation. Stemcell Technologies Inc. is a supplier of...
- This is a $6,493.50 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Stemcell Technologies Inc., a Canadian biotechnology company specializing in cell culture media, cell separation systems, and other life sciences research products. The contract is not set aside for small businesses. Stemcell Technologies Inc. primarily acts as a prime contractor, providing a range of biological materials, laboratory supplies, and specialized...
- This federal contract award to Stemcell Technologies Inc., a subsidiary of the Canadian company Stemcell Technologies, is for the delivery of semi-solid culture media. The contract has a ceiling value of $24,664.00 and is a firm fixed price purchase order. The award is set aside for small businesses. Stemcell Technologies Inc. is a key supplier of specialized biological materials, laboratory supplies, scientific equipment, and proprietary products to support biomedical research initiatives...
- STEMCELL Technologies Inc., a subsidiary of the Canadian parent company STEMCELL Technologies, received a $11,943 firm fixed-price contract award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) on June 8, 2022. This was a Blanket Purchase Agreement (BPA) call representing a repeat order for specialized cell isolation and enrichment products, specifically an EasySep Human Pan-B Cell Enrichment Kit and custom human isolation kit components featuring CD86...